← Leaderboards
Angela Rivers
University Of Florida
$2,882,643
Attributed
$2,882,643
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $437.3K · FY2010–23$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,882,643 · 3
By mechanism
R01$2,025,987 · 1
K01$696,756 · 1
R03$159,900 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Arun Srivastava$10,395,461
Others in their field
Top investigators on “United States”
- Leonard Freedman · Leidos Biomedical Research, Inc.$818,172,357
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$638,373,375
- David Heimbrook · Leidos Biomedical Research, Inc.$632,657,800
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United StatesAnemiaGenesMutationMouse ModelHematological DiseaseBone MarrowSickle Cell AnemiaChronicPainErythrocytesSicklingSickle HemoglobinPolymersEnvironmentClinical TrialsHematopoietic Stem CellsProteinsResearch PersonnelBeta GlobinEventAutophagocytosisDefectInherited
Grant awards (14)
The Role of Erythrocyte Mitochondrial Retention in Sickle Cell Disease$343,895
R01 · FY2023 · HL · contact PI
The Role of Erythrocyte Mitochondrial Retention in Sickle Cell Disease$93,404
R01 · FY2023 · HL · contact PI
The Role of Erythrocyte Mitochondrial Retention in Sickle Cell Disease$343,895
R01 · FY2022 · HL · contact PI
Diversity Supplement - The Role of Erythrocyte Mitochondrial Retention in Sickle Cell Disease$86,023
R01 · FY2022 · HL · contact PI
The Role of Erythrocyte Mitochondrial Retention in Sickle Cell Disease$359,270
R01 · FY2021 · HL · contact PI
The Role of Erythrocyte Mitochondrial Retention in Sickle Cell Disease$399,750
R01 · FY2020 · HL · contact PI
The Role of Erythrocyte Mitochondrial Retention in Sickle Cell Disease$399,750
R01 · FY2019 · HL · contact PI
Mitophagy as Potential Target in Sickle Cell Disease$79,950
R03 · FY2017 · HL · contact PI
Mitophagy as Potential Target in Sickle Cell Disease$79,950
R03 · FY2016 · HL · contact PI
Development of AAV vectors for the phenotypic correction of sickle cell disease$144,448
K01 · FY2014 · HL · contact PI
Development of AAV vectors for the phenotypic correction of sickle cell disease$144,448
K01 · FY2013 · HL · contact PI
Development of AAV vectors for the phenotypic correction of sickle cell disease$144,448
K01 · FY2012 · HL · contact PI
Development of AAV vectors for the phenotypic correction of sickle cell disease$131,706
K01 · FY2011 · HL · contact PI
Development of AAV vectors for the phenotypic correction of sickle cell disease$131,706
K01 · FY2010 · HL · contact PI